| Jennifer Jones, APRN | |
|
113 Virginia St, Chapin, SC 29036-8027 | |
| (803) 610-1723 | |
| Not Available |
| Full Name | Jennifer Jones |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Location | 113 Virginia St, Chapin, South Carolina |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073297222 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363L00000X | Nurse Practitioner | 27205 (South Carolina) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jennifer Jones, APRN 113 Virginia St, Chapin, SC 29036-8027 Ph: (803) 610-1723 | Jennifer Jones, APRN 113 Virginia St, Chapin, SC 29036-8027 Ph: (803) 610-1723 |
News Archive
A team of Australian researchers has made the ultimate move in the battle to beat melanoma, successfully trialing a combination of new treatments to stop the disease in its tracks and prevent it from spreading or metastasizing to distant organs.
Female lung transplant recipients are significantly more likely to suffer from a type of injury to the transplanted lung called primary graft dysfunction than male lung transplant patients, according to a study presented at the American Thoracic Society International Conference.
The U.S. Department of Health and Human Services (HHS) today announced new Consumer Assistance Grants program awards of nearly $30 million to help states and territories put patients in charge of their health care. These grants will support states' efforts to establish or strengthen consumer assistance programs that provide direct services to consumers with questions or concerns regarding their health insurance.
Seattle Genetics, Inc. and Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited today announced that brentuximab vedotin (SGN-35) will be featured in two oral presentations at the 52nd American Society of Hematology (ASH) Annual Meeting and Exposition being held December 4-7, 2010 in Orlando, FL.
VBL Therapeutics today announced the initiation of a Phase 2 efficacy and safety study evaluating lead compound VB-201 for the treatment of patients with psoriasis. VB-201 is poised to be a first-in-class, orally-administered immune response modifier expected to reduce inflammation in a broad range of conditions such as psoriasis.
› Verified 2 days ago
Marcia Hindman Green, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 2101 Dutch Fork Rd, Chapin, SC 29036 Phone: 910-742-9243 Fax: 888-746-1787 | |
Dr. Debra Seegers, PHD, FNP, PMHNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 2101 Dutch Fork Rd, Chapin, SC 29036 Phone: 910-742-9243 Fax: 888-746-1787 | |
Kimberly Trammell, AGNP-BC Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 2101 Dutch Fork Rd, Chapin, SC 29036 Phone: 910-742-9243 Fax: 888-746-1787 | |
April Maranville Dowdee, MSN, APRN-BC, AE-C Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 17 Island Dr, Chapin, SC 29036 Phone: 678-457-6882 | |
Denise Rallis-frutos, APN, DNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2101 Dutch Fork Rd, Chapin, SC 29036 Phone: 910-742-9243 Fax: 888-746-1787 | |
Brittany Nicole Jones, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 146 Four Foxes Ln, Chapin, SC 29036 Phone: 304-638-8654 |